Skip to content

ORBIT GALAXY 640CR1630Recalls & reported problems

Medos International Sàrl · ORBIT GALAXY Detachable Coil System with Tight Distal Loop technology 175cm d=2/3D D=16mm 30cm Contents: 1 Detachable Coil System with Tight Distal Loop technology and 1 luer valve. Coil Type: Complex Frame Note: ONLY use with TRUFILL DCS Syringe II. · Class 2

All models of ORBIT GALAXY (26)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10886704030508), received between Nov 26, 2025 and Nov 26, 2025 — classified as 1 injury.

The most frequently reported specific device problem is “Premature Separation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Premature Separation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 26, 2025Premature Separation; Premature Separation

    THE HEALTHCARE PROFESSIONAL REPORTED THAT THE FEMALE PATIENT WITH A RUPTURED LEFT POSTERIOR COMMUNICATING ARTERY ANEURYSM MEASURING APPROXIMATELY 8MM X 12MM UNDERWENT AN ENDOVASCULAR COIL EMBOLIZATION TREATMENT ON (B)(6) 2025. THE PHYSICIAN USED A 6FR SHUTTLE® GUIDING SHEATH (COOK MEDICAL), A 125CM CEREGLIDE 71 INTERMEDIATE CATHETER, AND A STRAIGHT SL-10® MICROCATHETER (STRYKER) AS THE COILING MICROCATHETER. THE FIRST COIL WAS A 14MM X 30CM ORBIT GALAXY COMPLEX FRAME WAS PLACED INTO THE ANEURYSM AND DEPLOYED WITHOUT INCIDENT. THE COMPLAINT COIL WAS THE SECOND COIL, A 16MM X 30CM ORBIT GALAXY COMPLEX FRAME (640CR1630 / LOT# UNKNOWN), WAS ATTEMPTED TO BE PLACED INTO THE ANEURYSM, BUT THE PHYSICIAN DID NOT LIKE HOW IT WAS FITTING AND DECIDED TO REMOVE THE COIL AND MOVE ON TO ANOTHER SIZE. WHEN THE DETACHMENT SYSTEM OF THE 16MM X 30CM ORBIT GALAXY COMPLEX FRAME WAS REMOVED FROM THE PATIENT, THERE WAS NO COIL ATTACHED TO THE SYSTEM. FLUOROSCOPY SHOWED THAT THE COIL WAS STILL HALFWAY IN THE ANEURYSM AND HALF IN THE MICROCATHETER. THE PHYSICIAN REMOVED THE MICROCATHETER AND THE COIL WAS NOT IN THE MICROCATHETER, IT WAS NOW IN THE CEREGLIDE 71 INTERMEDIATE CATHETER. THE PHYSICIAN WAS ABLE

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23660919 ↗

Other Device, Vascular, for Promoting Embolization devices

All Device, Vascular, for Promoting Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page